Label: CIPROFLOXACIN AND DEXAMETHASONE suspension/ drops

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 3, 2025

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to useCIPROFLOXACIN AND DEXAMETHASONE OTIC SUSPENSION safely and effectively. See full prescribing information for CIPROFLOXACIN AND ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions ...
  • 2 DOSAGE AND ADMINISTRATION
    2.1 Important Administration Instructions - • Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is for otic use (ears) only, and not for ophthalmic use, or for injection. • Shake well ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Otic Suspension: Each mL of ciprofloxacin and dexamethasone otic suspension USP, contains ciprofloxacin hydrochloride USP 0.3% (equivalent to 3 mg ciprofloxacin base) and dexamethasone USP, 0.1 ...
  • 4 CONTRAINDICATIONS
    Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to other quinolones, or to any of the components in ...
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Hypersensitivity Reactions - Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity ...
  • 6 ADVERSE REACTIONS
    The following serious adverse reactions are described elsewhere in the labeling: • Hypersensitivity Reactions [see Warnings and Precautions ( 5.1)] • Potential for Microbial Overgrowth with ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - There are no available data on ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension use in pregnant women to evaluate for a drug-associated risk of major ...
  • 10 OVERDOSAGE
    Due to the characteristics of this preparation, no toxic effects are to be expected with an otic overdose of this product.
  • 11 DESCRIPTION
    Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension USP, contains the quinolone antimicrobial, ciprofloxacin hydrochloride USP, combined with the corticosteroid, dexamethasone USP, in a ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Ciprofloxacin is a fluoroquinolone antibacterial [see Microbiology ( 12.4)]. Dexamethasone, a corticosteroid, has been shown to suppress inflammation by inhibiting ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - Carcinogenesis - Long-term carcinogenicity studies in mice and rats have been completed for ciprofloxacin. After daily oral doses of ...
  • 14 CLINICAL STUDIES
    In a randomized, multicenter, controlled clinical trial, ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension dosed 2 times per day for 7 days demonstrated clinical cures in the per protocol ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    How Supplied: Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, is white to off-white suspension supplied as follows: 7.5 mL fill in 10 mL low density polyethylene bottle. The ...
  • 17 PATIENT COUNSELING INFORMATION
    Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use). For Otic Use Only - Advise patients that ciprofloxacin 0.3% and dexamethasone 0.1% otic ...
  • PATIENT INFORMATION 
    Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension  - What is ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension? Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is a ...
  • Instructions for Use
    Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension  - This “Instructions for Use” contains information on how to use Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension ...
  • PACKAGE LABEL PRINCIPAL DISPLAY PANEL SECTION
    pdp
  • INGREDIENTS AND APPEARANCE
    Product Information